Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Effects of photobiomodulation on the differentiation, viability, and migration of C2C12 myoblasts exposed to different concentrations of dexamethasone

PBM further moderated the DEXA-induced reduction in IL-6 and TNF-α. Overall, PBM mitigated the effects of glucocorticoid-induced stress, indicating its potential as a complementary approach to help preserve myogenic function.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors examined whether a single 780-nm photobiomodulation session could reduce the harmful effects of dexamethasone on C2C12 myoblasts in culture. Dexamethasone reduced viability, fusion and migration, and photobiomodulation partially preserved these outcomes and moderated IL-6 and TNF-α changes without fully restoring control levels. As an in vitro cell study, the findings may not translate directly to living muscle.

Who or what was studied
C2C12 myoblasts (mouse cell line) exposed to dexamethasone
Wavelengths
780 nm
Limits stated in the abstract
The study is an in vitro cell experiment, and the abstract does not report a sample size or statistical details.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Glucocorticoid-induced muscle atrophy remains a clinical concern because of its broad impact on skeletal muscle structure, metabolism, and regenerative capacity. This study examined whether photobiomodulation (PBM) could lessen the damaging effects of dexamethasone (DEXA) on C2C12 myoblasts during differentiation. Cells were exposed to 5, 10, or 200 µM DEXA and evaluated after 24, 48, and 72 h. A single PBM session was delivered using a 780-nm laser (70 mW, 1.05 J, 26.25 J/cm2). Cell viability and proliferation were assessed by MTT and crystal violet assays; differentiation was analyzed through nuclear fusion and morphological staining; migration was measured using the wound-healing assay; and IL-6 and TNF-α levels were quantified by ELISA. DEXA reduced C2C12 viability, fusion, and migration in a time- and dose-dependent manner, particularly at 10 and 200 µM. PBM alone was not cytotoxic and, when combined with DEXA, partially preserved viability, enhanced proliferation, and supported early differentiation, although without restoring control levels. Migration was also mitigated, but not fully recovered. PBM further moderated the DEXA-induced reduction in IL-6 and TNF-α. Overall, PBM mitigated the effects of glucocorticoid-induced stress, indicating its potential as a complementary approach to help preserve myogenic function.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Energy density (fluence)
26.25 J/cm2
Power
70 mW
Total energy
1.05 J

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Laser, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies